The quality of the country's healthcare leaves much to be desired and there needs to be a state by state value-based delivery system, says Michael Porter, Harvard Business School professor.
Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are faster, better and cheaper to make than egg-based methods, reports CNBC's Mike Huckman.